Product Information
OLOPATADINE HCL 0.1% EYE DROPS is a generic product labeled by Rugby Laboratories, priced at $1.2228 per ML under NDC 00536130840. Its NADAC has been published 259 times since Jul 21, 2021.
FDA first approved this application on Aug 2, 2019.
Strength
1 mg/mL
Manufacturer
Rugby LaboratoriesNDC
00536130840
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
6/17/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209619FDA Approved
8/2/2019
On Market Since
1/5/2021
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.1% EYE DROPS has been published 259 times since Jul 21, 2021, and over the history we have for it it has declined 58.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2228 per ML |
|---|---|
| All-time high | $2.9580 (Aug 11, 2021) |
| All-time low | $1.0948 (Nov 20, 2024) |
| 52-week high | $1.2895 |
| 52-week low | $1.2029 |
| Median price | $1.3388 |
| Average price | $1.3944 |
| Largest weekly change | -41.6% (Aug 18, 2021) |
| Weeks tracked | 259 |
| Tracking since | Jul 21, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
+1.5%
1Y
-4.0%
3Y
-10.4%
5Y
-17.8%
All
-58.7%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olopatadine Hydrochloride Ophthalmic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROPS, manufactured by Rugby Laboratories, is $1.2228 per ML (NDC 00536130840), effective Jul 1, 2026.
How has the price of OLOPATADINE HCL 0.1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROPS has declined 58.7%. It has been tracked across 259 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROPS?
Since Jul 21, 2021, the NADAC for OLOPATADINE HCL 0.1% EYE DROPS has ranged from a low of $1.0948 (Nov 20, 2024) to a high of $2.9580 (Aug 11, 2021), with a median of $1.3388 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROPS?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EYE ALLERGY ITCH-RED 0.1% DROP, is $1.2205 per ML — about 0% below OLOPATADINE HCL 0.1% EYE DROPS.
Who manufactures OLOPATADINE HCL 0.1% EYE DROPS?
OLOPATADINE HCL 0.1% EYE DROPS (NDC 00536130840) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.